Warner Chilcott plc·4

Feb 15, 4:14 PM ET

Ellman Herman 4

4 · Warner Chilcott plc · Filed Feb 15, 2013

Insider Transaction Report

Form 4
Period: 2013-02-13
Ellman Herman
Senior V.P., Clinical Devel
Transactions
  • Award

    Ordinary shares, par value $0.01 per share

    2013-02-13+15,470183,580 total
  • Award

    Performance Restricted Share Units

    2013-02-13+15,02015,020 total
    Ordinary shares, par value $0.01 per share (15,020 underlying)
  • Award

    Option to purchase ordinary shares par value $0.01 per share

    2013-02-13+53,05053,050 total
    Exercise: $14.31Exp: 2023-02-12Ordinary shares, par value $0.01 per share (53,050 underlying)
Footnotes (3)
  • [F1]The reported securities are restricted share units, each of which represents a contingent right to receive one ordinary share of Warner Chilcott plc. The units vest and settle in four equal annual installments beginning on February 13, 2014.
  • [F2]The reported securities are performance restricted share units, each of which represents a contingent right to receive one ordinary share of Warner Chilcott plc. Up to 25% of the performance restricted share unit award is eligible to vest and settle in each of the four years following the date of grant depending upon achievement of performance targets.
  • [F3]The option vests in four equal annual installments beginning on February 13, 2014.

Documents

1 file
  • 4
    rrd368862.xmlPrimary

    FORM 4